Fig. 3
From: HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect
The relationship between the expression of serum and ascitic CA125 in ovarian cancer patients. a. The contents of serum and ascitic CA125 in the no chemotherapy group; b. The contents of serum and ascitic CA125 in the chemotherapy group; c. A comparison of the average values of serum and ascitic CA125 in the groups with and without chemotherapy (**p < 0.01); d & e. The comparison of serum and ascitic CA125 both in the groups with and without chemotherapy and according to the different categories of serum CA125 values (**p < 0.01, ***p < 0.001)